Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs


Understanding Neurodegenerative Disorders: Unraveling the Complexity of Brain Degeneration

Ranveer Rajat

Neurodegenerative disorders represent a heterogeneous group of chronic and progressive conditions characterized by the degeneration and loss of function of neurons in the central nervous system. These disorders encompass a wide range of conditions, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis (ALS), and various forms of dementia. The etiology of neurodegenerative disorders is multifactorial, involving genetic, environmental, and age-related factors. The hallmark of neurodegenerative disorders is the gradual and irreversible loss of neurons, leading to cognitive decline, motor dysfunction, and a decline in overall quality of life. Aberrant protein aggregation, mitochondrial dysfunction, oxidative stress, and neuroinflammation are among the common pathological mechanisms observed in these disorders. The clinical manifestations vary widely, reflecting the specific regions of the brain affected and the predominant neuronal populations involved. Current diagnostic approaches for neurodegenerative disorders often rely on clinical assessments, neuroimaging, and biomarker analyses. Despite advances in understanding the molecular and cellular underpinnings of these conditions, effective disease-modifying treatments remain elusive. Therapeutic interventions primarily aim at symptom management and slowing disease progression, emphasizing the importance of early and accurate diagnosis. This comprehensive review explores the diverse landscape of neurodegenerative disorders, encompassing their epidemiology, clinical manifestations, underlying pathophysiological mechanisms, diagnostic modalities, and current therapeutic strategies. Additionally, emerging research directions, including precision medicine approaches, neuroprotective strategies, and potential disease-modifying interventions, are discussed. The interdisciplinary nature of neurodegenerative disorder research is highlighted, emphasizing the need for collaboration among clinicians, neuroscientists, geneticists, and other stakeholders to advance our understanding and develop effective therapeutic interventions.